Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Mucolipidoses (D009081)
..Starting node
..expand
Neuraminidase 1 deficiency (C537366)

       Child Nodes:



 Sister Nodes: 
..expandMicrovillus inclusion disease (C537470)
..expandMucolipidosis 2 (C538602) Child1
..expandMucolipidosis II Alpha Beta (C567100)
..expandMucolipidosis III Alpha Beta, Atypical (C567099)
..expandMucolipidosis III Gamma (C565367)
..expandMucolipidosis type 3 A (C537367) Child1
..expandNephrosialidosis (C562606)
..expandNeuraminidase 1 deficiency (C537366)
..expandSialidosis, Type I (C564955)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:7924
Name:Neuraminidase 1 deficiency
Definition:
Alternative IDs:OMIM:256550
ParentIDs:MESH:D009081
TreeNumbers:C05.116.198.371/C537366 |C10.228.140.163.100.435.590/C537366 |C16.320.565.189.435.590/C537366 |C16.320.565.202.670/C537366 |C16.320.565.595.554.590/C537366 |C18.452.132.100.435.590/C537366 |C18.452.648.189.435.590/C537366 |C18.452.648.202.670/C537366 |C18.452.64
Synonyms:CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED |GLYCOPROTEIN NEURAMINIDASE DEFICIENCY |LIPOMUCOPOLYSACCHARIDOSIS |ML I |MUCOLIPIDOSIS I |MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED |Neu1 Deficiency |NEU1 DEFICIENCY SIALIDOSIS, TYPE I, INCLUDED |Neu Deficiency |N
Slim Mappings:Genetic disease (inborn)|Metabolic disease|Musculoskeletal disease|Nervous system disease
Reference: MedGen: C537366
MeSH: C537366
OMIM: 256550;

Genes: NEU1;
Phenotypes
1 HP:0000007Autosomal recessive inheritance
2 HP:0003461Increased urinary O-linked sialopeptides
3 HP:0001541Ascites
4 HP:0004333Bone-marrow foam cells
5 HP:0001640Cardiomegaly
6 HP:0001638Cardiomyopathy
7 HP:0000518Cataract
8 HP:0010729Cherry red spot of the macula
9 HP:0000280Coarse facial features
10 HP:0001310Dysmetria
11 HP:0000943Dysostosis multiplex
12 HP:0010655Epiphyseal stippling
13 HP:0000282Facial edema
14 HP:0001290Generalized hypotonia
15 HP:0002240Hepatomegaly
16 HP:0001789Hydrops fetalis
17 HP:0001347Hyperreflexia
18 HP:0001252Hypotonia
19 HP:0000023Inguinal hernia
20 HP:0001249Intellectual disability
21 HP:0001324Muscle weakness
22 HP:0001336Myoclonus
23 HP:0000639Nystagmus
24 HP:0000529Progressive visual loss
25 HP:0000093Proteinuria
26 HP:0001250Seizure
27 HP:0000407Sensorineural hearing impairment
28 HP:0004322Short stature
29 HP:0003202Skeletal muscle atrophy
30 HP:0001350Slurred speech
31 HP:0001744Splenomegaly
32 HP:0012061Urinary excretion of sialylated oligosaccharides
33 HP:0001922Vacuolated lymphocytes
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_000434.3(NEU1):c.1170C>G (p.Tyr390Ter)4758NEU1Pathogenic746607723RCV000202594; NMedGen:C0268226,OMIM:256550; MedGen:C0455988,OMIM:236750, Orphanet:ORPHA363999,SNOMED CT:27650900863182757431827574NM_000434.3:c.1170C>GNP_000425.1:p.Tyr390TerNC_000006.11:g.31827574G>C-C0455988 236750 Non-immune hydrops fetalis; C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.1088T>C (p.Leu363Pro)4758NEU1Pathogenic193922915RCV000002551; NMedGen:C0268226,OMIM:25655063182765631827656NM_000434.3:c.1088T>CNP_000425.1:p.Leu363ProNC_000006.11:g.31827656A>GOMIM Allelic Variant:608272.0005C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.893C>T (p.Ala298Val)4758NEU1Pathogenic104893981RCV000002561; NMedGen:C0268226,OMIM:25655063182794731827947NM_000434.3:c.893C>TNP_000425.1:p.Ala298ValNC_000006.11:g.31827947G>AOMIM Allelic Variant:608272.0015C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.779T>A (p.Phe260Tyr)4758NEU1Pathogenic104893977RCV000002550; NMedGen:C0268226,OMIM:25655063182823531828235NM_000434.3:c.779T>ANP_000425.1:p.Phe260TyrNC_000006.11:g.31828235A>TOMIM Allelic Variant:608272.0004C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.718T>C (p.Trp240Arg)4758NEU1Pathogenic104893978RCV000002557; NMedGen:C0268226,OMIM:25655063182829631828296NM_000434.3:c.718T>CNP_000425.1:p.Trp240ArgNC_000006.11:g.31828296A>GOMIM Allelic Variant:608272.0011C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.674G>C (p.Arg225Pro)4758NEU1Pathogenic104893980RCV000002560; NMedGen:C0268226,OMIM:25655063182834031828340NM_000434.3:c.674G>CNP_000425.1:p.Arg225ProNC_000006.11:g.31828340C>GOMIM Allelic Variant:608272.0014C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.353-2A>G4758NEU1Pathogenic864309513RCV000202579; NMedGen:C0268226,OMIM:256550; MedGen:C0455988,OMIM:236750, Orphanet:ORPHA363999,SNOMED CT:27650900863182922931829229NM_000434.3:c.353-2A>GNC_000006.11:g.31829229T>C-C0455988 236750 Non-immune hydrops fetalis; C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.272T>G (p.Leu91Arg)4758NEU1Pathogenic104893972RCV000002548; NMedGen:C0268226,OMIM:25655063182985631829856NM_000434.3:c.272T>GNP_000425.1:p.Leu91ArgNC_000006.11:g.31829856A>COMIM Allelic Variant:608272.0002C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.239C>T (p.Pro80Leu)4758NEU1Pathogenic104893985RCV000002556; NMedGen:C0268226,OMIM:25655063182988931829889NM_000434.3:c.239C>TNP_000425.1:p.Pro80LeuNC_000006.11:g.31829889G>AOMIM Allelic Variant:608272.0010C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.87G>A (p.Trp29Ter)4758NEU1Pathogenic104893984RCV000002555; NMedGen:C0268226,OMIM:25655063183046731830467NM_000434.3:c.87G>ANP_000425.1:p.Trp29TerNC_000006.11:g.31830467C>TOMIM Allelic Variant:608272.0009C0268226 256550 Sialidosis, type II
NM_000434.3(NEU1):c.69G>A (p.Trp23Ter)4758NEU1Pathogenic104893986RCV000002562; NMedGen:C0268226,OMIM:25655063183048531830485NM_000434.3:c.69G>ANP_000425.1:p.Trp23TerNC_000006.11:g.31830485C>TOMIM Allelic Variant:608272.0016C0268226 256550 Sialidosis, type II